KAINOSMED

The current price of 284620 is 2705 KRW — it has decreased by 4.08% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KAINOSMED stocks are traded under the ticker 284620.

284620 stock is 9.30% volatile and has beta coefficient of 1.23. Check out the list of the most volatile stocks — is KAINOSMED there?

Yes, you can track KAINOSMED financials in yearly and quarterly reports right on TradingView.

284620 stock has risen by 8.63% compared to the previous week, the month change is a 26.89% fall, over the last year KAINOSMED has showed a 60.10% decrease.

284620 net income for the last quarter is ‪−2.99 B‬ KRW, while the quarter before that showed ‪−3.86 B‬ KRW of net income which accounts for 22.52% change. Track more KAINOSMED financial stats to get the full picture.

No, 284620 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 284620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KAINOSMED stock right from TradingView charts — choose your broker and connect to your account.

284620 reached its all-time high on Aug 5, 2020 with the price of 30515 KRW, and its all-time low was 2430 KRW and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 19.00 employees. See our rating of the largest employees — is KAINOSMED on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KAINOSMED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KAINOSMED stock shows the sell signal. See more of KAINOSMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KAINOSMED EBITDA is ‪−15.53 B‬ KRW, and current EBITDA margin is ‪−5.81 K‬%. See more stats in KAINOSMED financial statements.